HIMS:NYE-Hims Hers Health Inc (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 19.04

Change

-3.20 (-14.39)%

Market Cap

USD 4.79B

Volume

0.03B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
UL Unilever PLC ADR

-0.69 (-1.11%)

USD 152.88B
KMB Kimberly-Clark Corporation

-0.10 (-0.07%)

USD 45.65B
CHD Church & Dwight Company Inc

-0.11 (-0.11%)

USD 25.11B
CLX The Clorox Company

-0.32 (-0.20%)

USD 19.67B
COTY Coty Inc

-0.11 (-1.42%)

USD 6.60B
ELF ELF Beauty Inc

-4.05 (-3.58%)

USD 6.22B
SPB Spectrum Brands Holdings Inc

+0.64 (+0.71%)

USD 2.51B
EPC Edgewell Personal Care Co

+0.55 (+1.55%)

USD 1.70B
PZC PIMCO California Municipal Inc..

+0.01 (+0.12%)

USD 0.63B
YSG Yatsen Holding

+0.08 (+2.15%)

USD 0.37B

ETFs Containing HIMS

EDOC:LSE Global X Telemedicine & D.. 4.72 % 0.00 %

+0.05 (+-0.08%)

USD 3.69M
EDOC:SW Global X Telemedicine & D.. 4.40 % 0.00 %

+0.09 (+-0.08%)

N/A
EDOG:LSE Global X Telemedicine & D.. 4.38 % 0.00 %

+0.05 (+-0.08%)

USD 0.38M
EDOC:AU BetaShares Digital Health.. 4.23 % 0.00 %

+0.18 (+-0.08%)

N/A
FDOC:LSE Fidelity Digital Health U.. 3.49 % 0.00 %

N/A

USD 3.02M
XHS SPDR® S&P Health Care Se.. 2.66 % 0.35 %

-1.28 (-0.08%)

USD 0.08B
RTWO:LSE L&G Russell 2000 US Small.. 0.60 % 0.00 %

+0.70 (+-0.08%)

USD 0.15B
RTWP:LSE Legal & General UCITS ETF.. 0.60 % 0.00 %

+68.00 (+-0.08%)

USD 0.15B
ETLZ:XETRA L&G Russell 2000 US Small.. 0.60 % 0.00 %

+0.13 (+-0.08%)

USD 0.09B
FFTY Innovator IBD® 50 ETF 0.00 % 0.80 %

-0.42 (-0.08%)

N/A
IBUY Amplify Online Retail ETF 0.00 % 0.65 %

-0.30 (-0.08%)

USD 0.17B
PSC Principal U.S. Small-Cap .. 0.00 % 0.38 %

-0.07 (-0.08%)

USD 0.66B

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 113.93% 82% B 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 113.93% 82% B 93% A
Trailing 12 Months  
Capital Gain 223.26% 82% B 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 223.26% 82% B 94% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 27.26% 88% B+ 86% B+
Dividend Return 27.26% 76% C+ 85% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 69.75% 12% F 13% F
Risk Adjusted Return 39.08% 53% F 56% F
Market Capitalization 4.79B 54% F 77% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.